# Anxiety and Depression: Shocking 1.83X Suicide Risk – Wigmore on Alcohol > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/anxiety-depression-suicide-risk-clinical-insights/ > **Published:** 2026-04-08T22:01:39-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:27:19-04:00 > **Clinical Summary:** Explore anxiety depression suicide risk and its clinical impact. Understand how cannabis use intersects with suicide risk in mental health care. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Mental HealthSuicide RiskAnxietyDepressionSubstance Use Why This Matters The 1.83-fold increased suicide risk with comorbid anxiety, depression, and substance use represents a critical clinical intersection where cannabis prescribing decisions carry heightened stakes. Understanding this risk profile helps clinicians better assess when cannabis therapeutics may serve as harm reduction versus when they might complicate an already vulnerable clinical picture. Clinical Summary The reported 1.83-fold increase in suicide risk among patients with anxiety, depression, and concurrent substance use reflects well-established clinical observations about psychiatric comorbidity and substance interactions. While the specific study methodology and population characteristics aren’t detailed in this summary, the magnitude aligns with existing literature on mental health and substance use disorder interactions. This risk elevation likely reflects both the direct neurobiological effects of substances on mood regulation and the compounding psychosocial stressors that often accompany polysubstance presentations. Dr. Caplan’s Take “This reminds me why I spend extra time with patients who present with this triad — anxiety, depression, and substance use patterns. When cannabis enters this clinical picture, whether therapeutically or recreationally, we’re not just treating symptoms; we’re potentially altering suicide risk in either direction.” Clinical Perspective 🧠 Clinicians should screen more intensively for suicidal ideation in patients presenting with this comorbid pattern, regardless of their [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) status. When considering cannabis therapeutics for anxiety or depression in patients with substance use histories, establish clear monitoring protocols and consider whether cannabis might serve as harm reduction from higher-risk substances or potentially complicate the clinical picture. The key is not avoiding cannabis categorically, but rather ensuring appropriate clinical oversight and safety planning. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Anxiety%20and%20Depression%3A%20Shocking%201.83X%20Suicide%20Risk%20-%20Wigmore%20on%20Alcohol%20%40drcaplan&url=https%3A//www.wigmoreonalcohol.com/anxiety-and-depression-substance-suicide/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.wigmoreonalcohol.com/anxiety-and-depression-substance-suicide/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Anxiety%20and%20Depression%3A%20Shocking%201.83X%20Suicide%20Risk%20-%20Wigmore%20on%20Alcohol%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.wigmoreonalcohol.com/anxiety-and-depression-substance-suicide/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.wigmoreonalcohol.com/anxiety-and-depression-substance-suicide/](https://www.wigmoreonalcohol.com/anxiety-and-depression-substance-suicide/) Table of Contents - [FAQ](#FAQ)[What mental health conditions does this cannabis research focus on?](#What_mental_health_conditions_does_this_cannabis_research_focus_on) - [Why is this cannabis study considered clinically relevant?](#Why_is_this_cannabis_study_considered_clinically_relevant) - [Is this research about medical cannabis or recreational use?](#Is_this_research_about_medical_cannabis_or_recreational_use) - [What type of healthcare providers should pay attention to these findings?](#What_type_of_healthcare_providers_should_pay_attention_to_these_findings) - [How significant are these research findings for current medical practice?](#How_significant_are_these_research_findings_for_current_medical_practice) - [Related](#Related) ## FAQ #### What mental health conditions does this cannabis research focus on? This research examines [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in relation to several key mental health conditions. The study specifically looks at anxiety, depression, and suicide risk among cannabis users. #### Why is this cannabis study considered clinically relevant? This research has been rated as having “Notable Clinical Interest” by CED Clinical Relevance. It represents emerging findings in [cannabis and mental health](https://cedclinic.com/endocannabinoid-system-fear-extinction/) that healthcare providers should monitor closely for potential clinical applications. #### Is this research about medical cannabis or recreational use? The article tags suggest this is [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) news from CED Clinic. This indicates the research likely focuses on [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) use rather than purely recreational consumption patterns. #### What type of healthcare providers should pay attention to these findings? Mental health professionals, primary care physicians, and [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) specialists should monitor these findings. The research may inform treatment decisions for patients with anxiety, depression, or suicidal ideation. #### How significant are these research findings for current medical practice? The findings are classified as “emerging” and “worth monitoring closely” rather than immediately practice-changing. Healthcare providers should stay informed about these developments as the research evolves and more data becomes available. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Research Suggests Cannabis Is Ineffective for Depression, Anxiety or PTSD](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) This article reviews evidence on cannabis efficacy for depression, anxiety, and PTSD, providing context for clinical decisions. [Read More](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) ['Plague-Level of Suicide': More States Embrace Public School Chaplains to Combat Crisis](https://cedclinic.com/youth-suicide-prevention-strategies-public-schools/) Explore innovative public health responses to rising suicide rates, relevant to mental health and suicide risk discussions. [Learn More](https://cedclinic.com/youth-suicide-prevention-strategies-public-schools/) [Genetic nurture in intergenerational transmission of substance use | Nature Communications](https://cedclinic.com/genetic-nurture-substance-use-intergenerational-risk/) Investigate genetic and environmental factors influencing substance use, important for understanding suicide risk in comorbid patients. [Explore Study](https://cedclinic.com/genetic-nurture-substance-use-intergenerational-risk/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).